Xeris Biopharma COO Kevin McCulloch reports sale of 15,000 shares for $153,487.50
XERS•Xeris Biopharma President and COO Kevin McCulloch sold 15,000 common shares on Nov. 2, 2026, at $10.2325 per share. After the sale, he directly held 1,584,208 shares and another 25,000 indirectly through his spouse.
1. Share sale
Kevin McCulloch, Xeris Biopharma’s president and chief operating officer, sold 15,000 common shares on Nov. 2, 2026, at $10.2325 per share, for $153,487.50. He directly held 1,584,208 shares after the sale, with another 25,000 held indirectly through his spouse.
